
Paul A Offit MD
Professor, Pediatrics, Perelman School of Medicine
Join to View Full Profile
3401 Civic Center BlvdChildrens Hospital of Phila Infectious DiseasesPhiladelphia, PA 19104
Phone+1 215-590-2017
Fax+1 215-590-2025
Dr. Offit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Infectious Diseases, 1980 - 1982
UPMC Medical EducationResidency, Pediatrics, 1977 - 1980
University of Maryland School of MedicineClass of 1977
Certifications & Licensure
PA State Medical License 1978 - 2026
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2011
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsChanged Recommendations for COVID-19 Vaccines for Children and Pregnant Women: A Failure of Process, Policy, and Science.Lawrence O Gostin, Dorit Reiss, Paul A Offit
JAMA. 2025-08-26 - Efficacy of Rotavirus Vaccines.Stanley A Plotkin, Paul Offit
The Pediatric Infectious Disease Journal. 2024-06-01 - 4 citationsCOVID-19 Vaccines in Young Children-Reassuring Evidence for Parents.Paul A Offit
JAMA Pediatrics. 2023-04-01
Journal Articles
- SARS-CoV-2 Vaccines and the Growing Threat of Viral VariantsPaul Offit, MD, JAMA
Authored Content
- Philly Vaccine Pioneer: Was the Human Cost of Doing Fewer COVID-19 Trials on Kids Worth It? | Expert OpinionSeptember 2021
Press Mentions
The Childhood Vaccine Schedule: What Is It and Why Do We Need One?October 17th, 2025
U.S. Measles Cases Continue to Climb, with Outbreaks Across the CountryOctober 13th, 2025
Why Don’t We Split the MMR into 3 Vaccines? Acting CDC Director’s Comments Spark ControversyOctober 9th, 2025- Join now to see all
Grant Support
- Enhancing Mucosal Immune Responses By MicroencapsulationNational Institute Of Allergy And Infectious Diseases2004–2005
- Enhancing Mucosal Immune Responses By MicroencapsulationNational Institute Of Allergy And Infectious Diseases2001–2003
- Enhancing Mucosal Immune Responses By MicroencapsulationNational Institute Of Allergy And Infectious Diseases2000
- Enhancement Of Immunogenicity By MicroencapsulationNational Institute Of Allergy And Infectious Diseases1995–1999
- Protection From Viral Gastroenteritis By Intestinal CtlsNational Institute Of Allergy And Infectious Diseases1990–1994
- Protection Against Viral Gastroenteritis By CtlsNational Institute Of Allergy And Infectious Diseases1988–1992
- Protection Against Gastroenteritis By Intestinal Cytotoxic T LymphocytesNational Center For Research Resources1990
- Rotavirus-Induced Gastroenteritis Protection By Intestine Cytotoxic T LymphocyteNational Center For Research Resources1989
- Immunological Protection Against Viral Gastroenteritis By Intestinal CellsNational Center For Research Resources1988
- Immune Protection Against Rotavirus InfectionNational Institute Of Allergy And Infectious Diseases1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









